Tempus Labs Inc - Company Profile
Powered by 
All the data and insights you need on Tempus Labs Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Tempus Labs Inc Strategy Report
- Understand Tempus Labs Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Tempus Labs Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP3891755A4 | Search Report | IDENTIFIZIERUNGS-, EXTRAKTIONS- UND VORHERSAGESYSTEM FÜR KLINISCHE KONZEPTE UND ZUGEHÖRIGE VERFAHREN | G06F40/274; G06F40/295; G06F40/30; G16H10/20; G16H10/60; G16H15/00; G16H70/00; G16H70/40 | September 07, 2022 |
| EP3906564A4 | Search Report | VERFAHREN UND VORRICHTUNG ZUR VORHERSAGE UND ANALYSE VON PATIENTENKOHORTENREAKTION, -PROGRESSION UND -ÜBERLEBEN | G06F17/18; G06F21/62; G06K9/6215; G06K9/6231; G06K9/6256; G06K9/6267; G06K9/6282; G06N20/00; G06N20/20; G06N5/003; G16H10/20; G16H10/60; G16H20/10; G16H20/40; G16H30/00; G16H50/20; G16H50/70; G16H80/00 | September 07, 2022 |
| WO2022159774A3 | Application | METHODS AND SYSTEMS FOR mRNA BOUNDARY ANALYSIS IN NEXT GENERATION SEQUENCING | G16B20/20; G16B25/10; G16B40/20 | September 01, 2022 |
| AU2021224670A1 | Application | Methods and systems for a liquid biopsy assay | G16B20/10; G16B30/00; G16H50/20 | September 01, 2022 |
| EP4048809A1 | Application | SYSTEME UND VERFAHREN ZUR VORHERSAGE DER THERAPEUTISCHEN EMPFINDLICHKEIT | C12Q1/6886; C12Q2600/106; G01N33/5082; G01N33/57415; G01N33/57449; G16B40/20 | August 31, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer